Skip to content
Catalyst

coenzyme Q10Finding

Coenzyme Q10 decreases glycated haemoglobin (HbA1c)

lowersLimited evidenceFinding

01 · The sentence it was drawn from

“Based on 31 trial arms (752 participants in the CoQ10 groups and 751 in the control groups), CoQ10 supplementation was associated with a significant reduction in HbA1c (WMD = −0.22 %; 95% CI: −0.37, −0.06; I 2 = 67.2 %; p < 0.001).”
Quoted verbatim from Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
This finding among the 64 findings on its endpoint

coenzyme Q10

Glycated haemoglobin (HbA1c)

lowers

Effect as reported

−0.22mean difference

CI −0.37 to −0.06

Who
Adults with disorders of lipid and/or glucose metabolism, pooled randomized trials of CoQ10 alone or with co-interventions, against placebo, no treatment or the same co-intervention without CoQ10
Dose studied
60 to 600 mg/day, pooled

Limited evidencePMID 42192187 · 2026

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limitedthis finding
  • very limited
  • insufficient

03 · The paper

Journal of diabetes research
What else it reported11 findings · 1 compound · 11 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6Y5K5VFT77H2BE70D2J1DKF